CLINICAL TRIALS PROFILE FOR BETAXON
✉ Email this page to a colleague
All Clinical Trials for BETAXON
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00061516 ↗ | Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension | Completed | Alcon Research | Phase 3 | 2003-01-01 | The purpose of this study is to evaluate the safety and efficacy of both BETAXON and AZOPT in pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at each visit. Patients will have a dilated fundus exam and corneal measurements taken at first and last visit. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BETAXON
Condition Name
Clinical Trial Progress for BETAXON
Clinical Trial Phase
Clinical Trial Sponsors for BETAXON
Sponsor Name